Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 2
2003 1
2004 2
2005 3
2006 4
2007 4
2008 7
2009 7
2010 9
2011 9
2012 8
2013 4
2014 13
2015 10
2016 1
2017 3
2018 4
2019 1
2020 3
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21372112

82 results
Results by year
Filters applied: . Clear all
Page 1
Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study.
Fleming JO, Isaak A, Lee JE, Luzzio CC, Carrithers MD, Cook TD, Field AS, Boland J, Fabry Z. Fleming JO, et al. Mult Scler. 2011 Jun;17(6):743-54. doi: 10.1177/1352458511398054. Epub 2011 Mar 3. Mult Scler. 2011. PMID: 21372112 Free PMC article. Clinical Trial.
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial.
Rosche B, Wernecke KD, Ohlraun S, Dörr JM, Paul F. Rosche B, et al. Trials. 2013 Apr 25;14:112. doi: 10.1186/1745-6215-14-112. Trials. 2013. PMID: 23782752 Free PMC article. Clinical Trial.
Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect.
Voldsgaard A, Bager P, Garde E, Åkeson P, Leffers AM, Madsen CG, Kapel C, Roepstorff A, Thamsborg SM, Melbye M, Siebner H, Søndergaard HB, Sellebjerg F, Sørensen PS. Voldsgaard A, et al. Mult Scler. 2015 Nov;21(13):1723-9. doi: 10.1177/1352458514568173. Epub 2015 Feb 19. Mult Scler. 2015. PMID: 25698173 Clinical Trial.
Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: Results of the HINT 2 clinical trial.
Fleming J, Hernandez G, Hartman L, Maksimovic J, Nace S, Lawler B, Risa T, Cook T, Agni R, Reichelderfer M, Luzzio C, Rolak L, Field A, Fabry Z. Fleming J, et al. Mult Scler. 2019 Jan;25(1):81-91. doi: 10.1177/1352458517736377. Epub 2017 Oct 24. Mult Scler. 2019. PMID: 29064315 Free PMC article. Clinical Trial.
Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients.
Benzel F, Erdur H, Kohler S, Frentsch M, Thiel A, Harms L, Wandinger KP, Rosche B. Benzel F, et al. J Helminthol. 2012 Sep;86(3):339-47. doi: 10.1017/S0022149X11000460. Epub 2011 Aug 15. J Helminthol. 2012. PMID: 21838960 Clinical Trial.
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T. Hurwitz BJ, et al. Clin Ther. 2008 Jun;30(6):1102-12. doi: 10.1016/j.clinthera.2008.06.013. Clin Ther. 2008. PMID: 18640466 Clinical Trial.
Immune responses and parasitological observations induced during probiotic treatment with medicinal Trichuris suis ova in a healthy volunteer.
Williams AR, Dige A, Rasmussen TK, Hvas CL, Dahlerup JF, Iversen L, Stensvold CR, Agnholt J, Nejsum P. Williams AR, et al. Immunol Lett. 2017 Aug;188:32-37. doi: 10.1016/j.imlet.2017.06.002. Epub 2017 Jun 8. Immunol Lett. 2017. PMID: 28602842
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Vollmer T, Key L, Durkalski V, Tyor W, Corboy J, Markovic-Plese S, Preiningerova J, Rizzo M, Singh I. Vollmer T, et al. Lancet. 2004 May 15;363(9421):1607-8. doi: 10.1016/S0140-6736(04)16205-3. Lancet. 2004. PMID: 15145635 Clinical Trial.
Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.
Llufriu S, Sepúlveda M, Blanco Y, Marín P, Moreno B, Berenguer J, Gabilondo I, Martínez-Heras E, Sola-Valls N, Arnaiz JA, Andreu EJ, Fernández B, Bullich S, Sánchez-Dalmau B, Graus F, Villoslada P, Saiz A. Llufriu S, et al. PLoS One. 2014 Dec 1;9(12):e113936. doi: 10.1371/journal.pone.0113936. eCollection 2014. PLoS One. 2014. PMID: 25436769 Free PMC article. Clinical Trial.
Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease.
Sandborn WJ, Elliott DE, Weinstock J, Summers RW, Landry-Wheeler A, Silver N, Harnett MD, Hanauer SB. Sandborn WJ, et al. Aliment Pharmacol Ther. 2013 Aug;38(3):255-63. doi: 10.1111/apt.12366. Epub 2013 Jun 3. Aliment Pharmacol Ther. 2013. PMID: 23730956 Free article. Clinical Trial.
82 results
Jump to page
Feedback